AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 29.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $12,000 | -29.4% | 14,709 | -41.5% | 0.00% | 0.0% |
| Q2 2019 | $17,000 | +240.0% | 25,134 | +287.0% | 0.00% | – |
| Q1 2019 | $5,000 | -70.6% | 6,495 | -40.3% | 0.00% | -100.0% |
| Q4 2018 | $17,000 | -67.9% | 10,884 | -32.1% | 0.00% | -75.0% |
| Q3 2018 | $53,000 | +96.3% | 16,031 | +33.6% | 0.00% | +100.0% |
| Q2 2018 | $27,000 | +2600.0% | 12,001 | +5669.7% | 0.00% | – |
| Q1 2018 | $1,000 | -99.0% | 208 | -99.4% | 0.00% | -100.0% |
| Q4 2017 | $96,000 | – | 34,378 | – | 0.01% | – |
| Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2016 | $1,000 | -97.5% | 1,076 | -97.6% | 0.00% | -100.0% |
| Q3 2016 | $40,000 | +21.2% | 45,344 | +34.0% | 0.00% | +33.3% |
| Q2 2016 | $33,000 | +3200.0% | 33,843 | +1967.4% | 0.00% | – |
| Q1 2016 | $1,000 | -66.7% | 1,637 | -37.8% | 0.00% | – |
| Q4 2015 | $3,000 | -70.0% | 2,630 | -67.9% | 0.00% | -100.0% |
| Q3 2015 | $10,000 | +400.0% | 8,190 | +478.8% | 0.00% | – |
| Q2 2015 | $2,000 | – | 1,415 | +1315.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 100 | -99.5% | 0.00% | -100.0% |
| Q1 2014 | $29,000 | +190.0% | 19,496 | +387.9% | 0.00% | +300.0% |
| Q2 2013 | $10,000 | – | 3,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |